Advances in hematopoietic stem cell transplantation in the Asia-Pacific region: the second report from APBMT 2005–2015

Registry Committee of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT)

Research output: Contribution to journalArticle

Abstract

Between 2005 and 2015, 138,165 hematopoietic stem cell transplantation (HSCT) were reported in 18 countries/regions in the Asia-Pacific region. In this report, we describe current trends in HSCT throughout the Asia-Pacific region and differences among nations in this region and various global registries. Since 2008, more than 10,000 HSCTs have been recorded each year by the Asia-Pacific Blood and Marrow Transplantation Group Data Center. Between 2005 and 2015, the greatest increase in the number of HSCTs was observed in Vietnam. Allogeneic HSCT was performed more frequently than autologous HSCT, and a majority of cases involved related donors. Regarding allogeneic HSCT, the use of cord blood has remained steady, especially in Japan, and the number of cases involving related HLA non-identical donors has increased rapidly, particularly in China. The incidence of hemoglobinopathy, a main indication for allogeneic HSCT in India, China, Iran, and Pakistan, increased nearly six-fold over the last decade. Among the 18 participating countries/regions, the transplant rate per population varied widely according to the absolute number of HSCTs and the national/regional population size. We believe that this report will not only benefit the AP region but will also provide information about HSCT to other regions worldwide.

Original languageEnglish
JournalBone Marrow Transplantation
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Hematopoietic Stem Cell Transplantation
China
Hemoglobinopathies
Vietnam
Pakistan
Iran
Population Density
Fetal Blood
Registries
India
Japan
Transplantation
Bone Marrow
Transplants
Incidence
Population

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Advances in hematopoietic stem cell transplantation in the Asia-Pacific region : the second report from APBMT 2005–2015. / Registry Committee of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT).

In: Bone Marrow Transplantation, 01.01.2019.

Research output: Contribution to journalArticle

Registry Committee of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT). / Advances in hematopoietic stem cell transplantation in the Asia-Pacific region : the second report from APBMT 2005–2015. In: Bone Marrow Transplantation. 2019.
@article{22c2dde5b2f44069aec5fd985303eff3,
title = "Advances in hematopoietic stem cell transplantation in the Asia-Pacific region: the second report from APBMT 2005–2015",
abstract = "Between 2005 and 2015, 138,165 hematopoietic stem cell transplantation (HSCT) were reported in 18 countries/regions in the Asia-Pacific region. In this report, we describe current trends in HSCT throughout the Asia-Pacific region and differences among nations in this region and various global registries. Since 2008, more than 10,000 HSCTs have been recorded each year by the Asia-Pacific Blood and Marrow Transplantation Group Data Center. Between 2005 and 2015, the greatest increase in the number of HSCTs was observed in Vietnam. Allogeneic HSCT was performed more frequently than autologous HSCT, and a majority of cases involved related donors. Regarding allogeneic HSCT, the use of cord blood has remained steady, especially in Japan, and the number of cases involving related HLA non-identical donors has increased rapidly, particularly in China. The incidence of hemoglobinopathy, a main indication for allogeneic HSCT in India, China, Iran, and Pakistan, increased nearly six-fold over the last decade. Among the 18 participating countries/regions, the transplant rate per population varied widely according to the absolute number of HSCTs and the national/regional population size. We believe that this report will not only benefit the AP region but will also provide information about HSCT to other regions worldwide.",
author = "{Registry Committee of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT)} and Minako Iida and Yoshihisa Kodera and Anthony Dodds and Ho, {Aloysius Yew Leng} and Ian Nivison-Smith and Akter, {Mafruha Rumana} and Tong Wu and Lie, {Albert Kwok Wai} and Ardeshir Ghavamzadeh and Kang, {Hyoung Jin} and Ong, {Tee Chuan} and Gyi, {Aye Aye} and Tasneem Farzana and Honorata Baylon and Lallindra Gooneratne and Tang, {Jih Luh} and Udomsak Bunworasate and Huynh, {Van Man} and Alok Srivastava and Shinichiro Okamoto and Yoshiko Atsuta",
year = "2019",
month = "1",
day = "1",
doi = "10.1038/s41409-019-0554-9",
language = "English",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Advances in hematopoietic stem cell transplantation in the Asia-Pacific region

T2 - the second report from APBMT 2005–2015

AU - Registry Committee of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT)

AU - Iida, Minako

AU - Kodera, Yoshihisa

AU - Dodds, Anthony

AU - Ho, Aloysius Yew Leng

AU - Nivison-Smith, Ian

AU - Akter, Mafruha Rumana

AU - Wu, Tong

AU - Lie, Albert Kwok Wai

AU - Ghavamzadeh, Ardeshir

AU - Kang, Hyoung Jin

AU - Ong, Tee Chuan

AU - Gyi, Aye Aye

AU - Farzana, Tasneem

AU - Baylon, Honorata

AU - Gooneratne, Lallindra

AU - Tang, Jih Luh

AU - Bunworasate, Udomsak

AU - Huynh, Van Man

AU - Srivastava, Alok

AU - Okamoto, Shinichiro

AU - Atsuta, Yoshiko

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Between 2005 and 2015, 138,165 hematopoietic stem cell transplantation (HSCT) were reported in 18 countries/regions in the Asia-Pacific region. In this report, we describe current trends in HSCT throughout the Asia-Pacific region and differences among nations in this region and various global registries. Since 2008, more than 10,000 HSCTs have been recorded each year by the Asia-Pacific Blood and Marrow Transplantation Group Data Center. Between 2005 and 2015, the greatest increase in the number of HSCTs was observed in Vietnam. Allogeneic HSCT was performed more frequently than autologous HSCT, and a majority of cases involved related donors. Regarding allogeneic HSCT, the use of cord blood has remained steady, especially in Japan, and the number of cases involving related HLA non-identical donors has increased rapidly, particularly in China. The incidence of hemoglobinopathy, a main indication for allogeneic HSCT in India, China, Iran, and Pakistan, increased nearly six-fold over the last decade. Among the 18 participating countries/regions, the transplant rate per population varied widely according to the absolute number of HSCTs and the national/regional population size. We believe that this report will not only benefit the AP region but will also provide information about HSCT to other regions worldwide.

AB - Between 2005 and 2015, 138,165 hematopoietic stem cell transplantation (HSCT) were reported in 18 countries/regions in the Asia-Pacific region. In this report, we describe current trends in HSCT throughout the Asia-Pacific region and differences among nations in this region and various global registries. Since 2008, more than 10,000 HSCTs have been recorded each year by the Asia-Pacific Blood and Marrow Transplantation Group Data Center. Between 2005 and 2015, the greatest increase in the number of HSCTs was observed in Vietnam. Allogeneic HSCT was performed more frequently than autologous HSCT, and a majority of cases involved related donors. Regarding allogeneic HSCT, the use of cord blood has remained steady, especially in Japan, and the number of cases involving related HLA non-identical donors has increased rapidly, particularly in China. The incidence of hemoglobinopathy, a main indication for allogeneic HSCT in India, China, Iran, and Pakistan, increased nearly six-fold over the last decade. Among the 18 participating countries/regions, the transplant rate per population varied widely according to the absolute number of HSCTs and the national/regional population size. We believe that this report will not only benefit the AP region but will also provide information about HSCT to other regions worldwide.

UR - http://www.scopus.com/inward/record.url?scp=85065924078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065924078&partnerID=8YFLogxK

U2 - 10.1038/s41409-019-0554-9

DO - 10.1038/s41409-019-0554-9

M3 - Article

AN - SCOPUS:85065924078

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

ER -